Artificial intelligence (AI)-derived software to help clinical decision making in stroke | DG57 | | |
Kurin Lock for blood culture collection | MTG77 | | |
GaitSmart rehabilitation exercise programme for gait and mobility issues | MTG78 | | |
Devices for remote monitoring of Parkinson's disease | DG51 | | |
Sebelipase alfa for treating Wolman disease | HST30 | | |
Velmanase alfa for treating alpha-mannosidosis | HST29 | | |
Birch bark extract for treating epidermolysis bullosa | HST28 | | |
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | DG56 | | |
Afamelanotide for treating erythropoietic protoporphyria | HST27 | | |
KardiaMobile for detecting atrial fibrillation | MTG64 | | |
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | DG55 | | |
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care | DG48 | | |
Transperineal biopsy for diagnosing prostate cancer | DG54 | | |
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | DG52 | | |
MRI fusion biopsy systems for diagnosing prostate cancer | DG53 | | |
Lumasiran for treating primary hyperoxaluria type 1 | HST25 | | |
Onasemnogene abeparvovec for treating spinal muscular atrophy | HST15 | | |
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency | HST26 | | |
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy | HST24 | | |
AposHealth for knee osteoarthritis | MTG76 | | |
UrgoStart for treating diabetic foot ulcers and leg ulcers | MTG42 | | |
Asfotase alfa for treating paediatric-onset hypophosphatasia | HST23 | | |
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene | HST22 | | |
Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
Tobacco: preventing uptake, promoting quitting and treating dependence | NG209 | | |
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education | NG213 | | |
MRI-based technologies for assessing non-alcoholic fatty liver disease | DG50 | | |
Memokath 051 Ureter stent for ureteric obstruction | MTG75 | | |
Optilume for treating recurrent bulbar urethral strictures | MTG73 | | |
GreenLight XPS for treating benign prostatic hyperplasia | MTG74 | | |
Advocacy services for adults with health and social care needs | NG227 | | |
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer | MTG72 | | |
Neuropad for detecting preclinical diabetic peripheral neuropathy | MTG38 | | |
Self-harm: assessment, management and preventing recurrence | NG225 | | |
Faecal microbiota transplant for recurrent Clostridioides difficile infection | MTG71 | | |
iFuse for treating chronic sacroiliac joint pain | MTG39 | | |
SecurAcath for securing percutaneous catheters | MTG34 | | |
PLGF-based testing to help diagnose suspected preterm pre-eclampsia | DG49 | | |
PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites | MTG9 | | |
Setmelanotide for treating obesity caused by LEPR or POMC deficiency | HST21 | | |
Social, emotional and mental wellbeing in primary and secondary education | NG223 | | |
MiraQ for assessing graft flow during coronary artery bypass graft surgery | MTG8 | | |
Reducing sexually transmitted infections | NG221 | | |
Peristeen Plus transanal irrigation system for managing bowel dysfunction | MTG36 | | |
Thopaz+ portable digital system for managing chest drains | MTG37 | | |
Social work with adults experiencing complex needs | NG216 | | |
Sleepio to treat insomnia and insomnia symptoms | MTG70 | | |
Vaccine uptake in the general population | NG218 | | |
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over | HST20 | | |
Epilepsies in children, young people and adults | NG217 | | |
Elosulfase alfa for treating mucopolysaccharidosis type 4A | HST19 | | |
myCOPD for managing chronic obstructive pulmonary disease | MTG68 | | |
UroShield for preventing catheter-associated urinary tract infections | MTG69 | | |
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) | DG47 | | |
Atidarsagene autotemcel for treating metachromatic leukodystrophy | HST18 | | |
Integrated health and social care for people experiencing homelessness | NG214 | | |
Prontosan for treating acute and chronic wounds | MTG67 | | |
3C Patch for treating diabetic foot ulcers | MTG66 | | |
Mental wellbeing at work | NG212 | | |
PredictSURE IBD and IBDX to guide treatment of Crohn's disease | DG45 | | |
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | DG46 | | |
Odevixibat for treating progressive familial intrahepatic cholestasis | HST17 | | |
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care | MTG65 | | |
Endo-SPONGE for treating low rectal anastomotic leak | MTG63 | | |
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections | MTG62 | | |
Synergo for non-muscle-invasive bladder cancer | MTG61 | | |
Givosiran for treating acute hepatic porphyria | HST16 | | |
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea | DG44 | | |
Looked-after children and young people | NG205 | | |
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography | MTG60 | | |
ENDURALIFE powered CRT-D devices for treating heart failure | MTG33 | | |
Plus Sutures for preventing surgical site infection | MTG59 | | |
Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography | MTG32 | | |
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers | MTG20 | | |
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia | MTG58 | | |
Danis stent for acute oesophageal variceal bleeding | MTG57 | | |
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography | DG43 | | |
Alpha-Stim AID for anxiety disorders | MTG56 | | |
Safeguarding adults in care homes | NG189 | | |
Metreleptin for treating lipodystrophy | HST14 | | |
Leukomed Sorbact for preventing surgical site infection | MTG55 | | |
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal | MTG54 | | |
The PLASMA system for transurethral resection and haemostasis of the prostate | MTG53 | | |
Zio XT for detecting cardiac arrhythmias | MTG52 | | |
Testing strategies for Lynch syndrome in people with endometrial cancer | DG42 | | |
Volanesorsen for treating familial chylomicronaemia syndrome | HST13 | | |
SEM Scanner 200 for preventing pressure ulcers | MTG51 | | |
Behaviour change: digital and mobile health interventions | NG183 | | |
Axonics sacral neuromodulation system for treating refractory overactive bladder | MTG50 | | |
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | DG41 | | |
High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | | |
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia | MTG49 | | |
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | DG39 | | |
PneuX to prevent ventilator-associated pneumonia | MTG48 | | |
SepsiTest assay for rapidly identifying bloodstream bacteria and fungi | DG20 | | |
Antenatal and postnatal mental health: clinical management and service guidance | CG192 | | |
Episcissors-60 for mediolateral episiotomy | MTG47 | | |
Supporting adult carers | NG150 | | |
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C | MTG27 | | |
Indoor air quality at home | NG149 | | |
gammaCore for cluster headache | MTG46 | | |
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 | HST12 | | |
Workplace health: long-term sickness absence and capability to work | NG146 | | |
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast | DG37 | | |
Rapid tests for group A streptococcal infections in people with a sore throat | DG38 | | |
End of life care for adults: service delivery | NG142 | | |
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations | HST11 | | |
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing | MTG12 | | |
Tegaderm CHG securement dressing for vascular access sites in critically ill adults | MTG25 | | |
Patisiran for treating hereditary transthyretin amyloidosis | HST10 | | |
Alcohol interventions in secondary and further education | NG135 | | |
PICO negative pressure wound dressings for closed surgical incisions | MTG43 | | |
End of life care for infants, children and young people with life-limiting conditions: planning and management | NG61 | | |
Motor neurone disease: assessment and management | NG42 | | |
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis | DG36 | | |
Ambu aScope4 Broncho for use in unexpected difficult airways | MTG14 | | |
Endocuff Vision for assisting visualisation during colonoscopy | MTG45 | | |
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters | MTG24 | | |
Inotersen for treating hereditary transthyretin amyloidosis | HST9 | | |
Curos for preventing infections when using needleless connectors | MTG44 | | |
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care | DG35 | | |
The Debrisoft monofilament debridement pad for use in acute or chronic wounds | MTG17 | | |
Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain | MTG41 | | |
Cerebral palsy in adults | NG119 | | |
Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers | MTG40 | | |
Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms | MTG10 | | |
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | DG34 | | |
Burosumab for treating X-linked hypophosphataemia in children and young people | HST8 | | |
Decision-making and mental capacity | NG108 | | |
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta | MTG16 | | |
Preventing suicide in community and custodial settings | NG105 | | |
Flu vaccination: increasing uptake | NG103 | | |
Community pharmacies: promoting health and wellbeing | NG102 | | |
Biomarker tests to help diagnose preterm labour in women with intact membranes | DG33 | | |
Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I | DG32 | | |
Care and support of people growing older with learning disabilities | NG96 | | |
Learning disabilities and behaviour that challenges: service design and delivery | NG93 | | |
Physical activity and the environment | NG90 | | |
People's experience in adult social care services: improving the experience of care and support for people using adult social care services | NG86 | | |
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency | HST7 | | |
Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) | DG14 | | |
Tests in secondary care to identify people at high risk of ovarian cancer | DG31 | | |
Cystic fibrosis: diagnosis and management | NG78 | | |
Child abuse and neglect | NG76 | | |
Intermediate care including reablement | NG74 | | |
Type 2 diabetes: prevention in people at high risk | PH38 | | |
Vitamin D: supplement use in specific population groups | PH56 | | |
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment | MTG2 | | |
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | DG3 | | |
Air pollution: outdoor air quality and health | NG70 | | |
Eliglustat for treating type 1 Gaucher disease | HST5 | | |
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
Obesity: working with local communities | PH42 | | |
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | DG28 | | |
Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
Sexually transmitted infections: condom distribution schemes | NG68 | | |
Managing medicines for adults receiving social care in the community | NG67 | | |
Patient group directions | MPG2 | | |
Mental health of adults in contact with the criminal justice system | NG66 | | |
Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
Migalastat for treating Fabry disease | HST4 | | |
Drug misuse prevention: targeted interventions | NG64 | | |
Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
HumiGard for preventing inadvertent perioperative hypothermia | MTG31 | | |
Cerebral palsy in under 25s: assessment and management | NG62 | | |
Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
XprESS multi sinus dilation system for treating chronic sinusitis | MTG30 | | |
HIV testing: increasing uptake among people who may have undiagnosed HIV | NG60 | | |
Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
Physical health of people in prison | NG57 | | |
Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
Harmful sexual behaviour among children and young people | NG55 | | |
Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
Transition between inpatient mental health settings and community or care home settings | NG53 | | |
Oral health for adults in care homes | NG48 | | |
ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
Controlled drugs: safe use and management | NG46 | | |
Workplace health: management practices | NG13 | | |
Community engagement: improving health and wellbeing and reducing health inequalities | NG44 | | |
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | MTG28 | | |
Transition from children's to adults' services for young people using health or social care services | NG43 | | |
Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | DG22 | | |
Skin cancer prevention | PH32 | | |
Sunlight exposure: risks and benefits | NG34 | | |
Older people: independence and mental wellbeing | NG32 | | |
Care of dying adults in the last days of life | NG31 | | |
Oral health promotion: general dental practice | NG30 | | |
Transition between inpatient hospital settings and community or care home settings for adults with social care needs | NG27 | | |
Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | DG19 | | |
Older people with social care needs and multiple long-term conditions | NG22 | | |
Developing and updating local formularies | MPG1 | | |
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset | NG16 | | |
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | DG18 | | |
Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | NG15 | | |
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
Preventing excess weight gain | NG7 | | |
Excess winter deaths and illness and the health risks associated with cold homes | NG6 | | |
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy | MTG22 | | |
Eculizumab for treating atypical haemolytic uraemic syndrome | HST1 | | |
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | DG16 | | |
The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury | MTG21 | | |
Maternal and child nutrition | PH11 | | |
Oral health: local authorities and partners | PH55 | | |
Physical activity: exercise referral schemes | PH54 | | |
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | DG13 | | |
The geko device for reducing the risk of venous thromboembolism | MTG19 | | |
Weight management: lifestyle services for overweight or obese adults | PH53 | | |
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | DG12 | | |
Contraceptive services for under 25s | PH51 | | |
Needle and syringe programmes | PH52 | | |
Managing medicines in care homes | SC1 | | |
Domestic violence and abuse: multi-agency working | PH50 | | |
Behaviour change: individual approaches | PH49 | | |
Weight management: lifestyle services for overweight or obese children and young people | PH47 | | |
Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | DG11 | | |
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | DG9 | | |
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | DG8 | | |
Falls in older people: assessing risk and prevention | CG161 | | |
Physical activity: brief advice for adults in primary care | PH44 | | |
Antisocial personality disorder: prevention and management | CG77 | | |
Hepatitis B and C testing: people at risk of infection | PH43 | | |
Physical activity: walking and cycling | PH41 | | |
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | DG6 | | |
Social and emotional wellbeing: early years | PH40 | | |
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | DG5 | | |
Mega Soft Patient Return Electrode for use during monopolar electrosurgery | MTG11 | | |
Healthcare-associated infections: prevention and control | PH36 | | |
The EOS 2D/3D imaging system | DG1 | | |
Ambulight PDT for the treatment of non-melanoma skin cancer | MTG6 | | |
The MIST Therapy system for the promotion of wound healing | MTG5 | | |
Type 2 diabetes prevention: population and community-level interventions | PH35 | | |
Unintentional injuries: prevention strategies for under 15s | PH29 | | |
Unintentional injuries in the home: interventions for under 15s | PH30 | | |
Unintentional injuries on the road: interventions for under 15s | PH31 | | |
Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
Weight management before, during and after pregnancy | PH27 | | |
Cardiovascular disease prevention | PH25 | | |
Alcohol-use disorders: prevention | PH24 | | |
Improving outcomes for people with skin tumours including melanoma | CSG8 | | |
Rehabilitation after critical illness in adults | CG83 | | |
Borderline personality disorder: recognition and management | CG78 | | |
Physical activity for children and young people | PH17 | | |
Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
Cardiovascular disease: identifying and supporting people most at risk of dying early | PH15 | | |
Physical activity in the workplace | PH13 | | |
Behaviour change: general approaches | PH6 | | |
Drug misuse in over 16s: opioid detoxification | CG52 | | |
Drug misuse in over 16s: psychosocial interventions | CG51 | | |
Improving outcomes for people with brain and other central nervous system tumours | CSG10 | | |
Improving outcomes for people with sarcoma | CSG9 | | |
Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
Improving outcomes in children and young people with cancer | CSG7 | | |
Improving outcomes in head and neck cancers | CSG6 | | |
Improving supportive and palliative care for adults with cancer | CSG4 | | |
Improving outcomes in urological cancers | CSG2 | | |
Improving outcomes in breast cancer | CSG1 | | |